Structural basis for the transforming activity of human cancer-related signaling adaptor protein CRK

Nature Structural and Molecular Biology

Volumn 14, Issue 6, 2007, Pages 503-510

  Kobashigawa, Yoshihiro ^a   Sakai, Mieko ^b   Naito, Masato ^a   Yokochi, Masashi ^a   Kumeta, Hiroyuki ^a   Makino, Yoshinori ^b   Ogura, Kenji ^a   Tanaka, Shinya ^b   Inagaki, Fuyuhiko ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

^b HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTOR PROTEIN; PROTEIN CRK; PROTEIN CRKI; PRTOEIN CRKII; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BIOLOGICAL ACTIVITY; FIBROBLAST; MUTATIONAL ANALYSIS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN STRUCTURE; RAT; RODENT;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; AMINO ACID SEQUENCE; ANIMALS; BROMODEOXYURIDINE; CELL TRANSFORMATION, NEOPLASTIC; DNA MUTATIONAL ANALYSIS; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MUTATION; PROTEIN BINDING; PROTEIN ISOFORMS; PROTEIN STRUCTURE, TERTIARY; PROTO-ONCOGENE PROTEINS C-CRK; SIGNAL TRANSDUCTION;

RODENTIA;

EID: 34249902061     PISSN: 15459993     EISSN: 15459985     Source Type: Journal    
DOI: 10.1038/nsmb1241     Document Type: Article

References (37)

1. Cheresh, D.A., Leng, J. & Klemke, R.L. Regulation of cell contraction and membrane ruffling by distinct signals in migratory cells. J. Cell Biol. 146, 1107-1116 (1999).
2. Tanaka, S., Ouchi, T. & Hanafusa, H. Downstream of Crk: activation of JNK by v-Crk through the guanine nucleotide exchange protein C3G. Proc. Natl. Acad. Sci. USA 94, 2356-2361 (1997).
3. Tanaka, S. et al. Both the SH2 and SH3 domains of human Crk protein are required for neuronal differentiation of PC12 cells. Mol. Cell. Biol. 13, 4409-4415 (1993).
4. Kiyokawa, E. et al. Activation of Rac1 by a Crk SH3-binding protein, DOCK180. Genes Dev. 12, 3331-3336 (1998).
5. Oktay, M., Wary, K.K., Dans, M., Birge, R.B. & Giancotti, F.G. Integrin-mediated activation of focal adhesion kinase is required for signaling to Jun NH2-terminal kinase and progression through the G1 phase of the cell cycle. J. Cell Biol. 145, 1461-1469 (1999).
6. Feller, S.M. Crk family adaptors - signalling complex formation and biological roles. Oncogene 20, 6348-6371 (2001).
7. Linghu, H. et al. Involvement of adaptor protein Crk in malignant feature of human ovarian cancer cell line MCAS. Oncogene 25, 3547-3556 (2006).
8. Nishihara, H. et al. Molecular and immunohistochemical analysis of adaptor protein Crk in human cancers. Cancer Lett. 180, 55-61 (2002).
9. Beer, D.G. et al. Gene-expression profiles predict survival of patients with lung adenocarcinoma. Nat. Med. 8, 816-824 (2002).
10. Miller, C.T. et al. Increased C-Crk proto-oncogene expression is associated with an aggressive phenotype in lung adenocarcinomas. Oncogene 22, 7950-7957 (2003).
11. Takino, T. et al. CrkI adapter protein modulates cell migration and invasion in glioblastoma. Cancer Res. 63, 2335-2337 (2003).
12. Konishi, H. et al. Detailed characterization of a homozygously deleted region corresponding to a candidate tumor suppressor locus at distal 17p13.3 in human lung cancer. Oncogene 22, 1892-1905 (2003).
13. Watanabe, T. et al. Adaptor molecule Crk is required for sustained phosphorylation of Grb2-associated binder 1 and hepatocyte growth factor-induced cell motility of human synovial sarcoma cell lines. Mol. Cancer Res. 4, 499-510 (2006).
14. Matsuda, M. et al. Two species of human Crk cDNA encode proteins with distinct biological activities. Mol. Cell. Biol. 12, 3482-3489 (1992).
15. Feller, S.M., Knudsen, B. & Hanafusa, H. c-Abl kinase regulates the protein binding activity of c-Crk. EMBO J. 13, 2341-2351 (1994).
16. Rosen, M.K. et al. Direct demonstration of an intramolecular SH2-phosphotyrosine interaction in the Crk protein. Nature 374, 477-479 (1995).
17. Guinier, A. & Fournet, G. Small-Angle Scattering of X-ray (John Wiley & Sons, New York, 1955).
18. Kurokawa, K. et al. A pair of fluorescent resonance energy transfer-based probes for tyrosine phosphorylation of the CrkII adaptor protein in vivo. J. Biol. Chem. 276, 31305-31310 (2001).
19. Cotton, G.J. & Muir, T.W. Generation of a dual-labeled fluorescence biosensor for Crk-II phosphorylation using solid-phase expressed protein ligation. Chem. Biol. 7, 253-261 (2000).
20. Yuzawa, S. et al. Solution structure of Grb2 reveals extensive flexibility necessary for target recognition. J. Mol. Biol. 306, 527-537 (2001).
21. Donaldson, L.W., Gish, G., Pawson, T., Kay, L.E. & Forman-Kay, J.D. Structure of a regulatory complex involving the Abl SH3 domain, the Crk SH2 domain, and a Crk-derived phosphopeptide. Proc. Natl. Acad. Sci. USA 99, 14053-14058 (2002).
22. Guntert, P. Automated NMR structure calculation with CYANA. Methods Mol. Biol. 278, 353-378 (2004).
23. Brunger, A.T. et al. Crystallography & NMR system: a new software suite for macromolecular structure determination. Acta Crystallogr. D Biol. Crystallogr. 54, 905-921 (1998).
24. Anafi, M., Rosen, M.K., Gish, G.D., Kay, L.E. & Pawson, T. A potential SH3 domain-binding site in the Crk SH2 domain. J. Biol. Chem. 271, 21365-21374 (1996).
25. Wu, X. et al. Structural basis for the specific interaction of lysine-containing proline-rich peptides with the N-terminal SH3 domain of c-Crk. Structure 3, 215-226 (1995).
26. Shishido, T. et al. Crk family adaptor proteins trans-activate c-Abl kinase. Genes Cells 6, 431-440 (2001).
27. Ogawa, S. et al. The C-terminal SH3 domain of the mouse c-Crk protein negatively regulates tyrosine-phosphorylation of Crk associated p130 in rat 3Y1 cells. Oncogene 9, 1669-1678 (1994).
28. Akakura, S. et al. C-terminal SH3 domain of CrkII regulates the assembly and function of the DOCK180/ELMO Rac-GEF. J. Cell. Physiol. 204, 344-351 (2005).
29. Zvara, A. et al. Activation of the focal adhesion kinase signaling pathway by structural alterations in the carboxyl-terminal region of c-Crk II. Oncogene 20, 951-961 (2001).
30. Muralidharan, V. et al. Solution structure and folding characteristics of the C-terminal SH3 domain of c-Crk-II. Biochemistry 45, 8874-8884 (2006).
31. Sabe, H., Okada, M., Nakagawa, H. & Hanafusa, H. Activation of c-Src in cells bearing v-Crk and its suppression by Csk. Mol. Cell. Biol. 12, 4706-4713 (1992).
32. Sarkar, P., Reichman, C., Saleh, T., Birge, R.B. & Kalodimos, C.G. Proline cis-trans isomerization controls autoinhibition of a signaling protein. Mol. Cell 25, 413-426 (2007).
33. Cavanagh, J., Fairbrother, W.J., Palmer, A.G., III & Skelton,, N.J. Protein NMR Spectroscopy: Principles and Practice (Academic Press, San Diego, 1996).
34. Bartels, C., Xia, T.-H., Billeter, M., Güntert, P. & Wüthrich, K. The program XEASY for computer-supported NMR spectral analysis of biological macromolecules. J. Biomol. NMR 6, 1-10 (1995).
35. Cornilescu, G., Delaglio, F. & Bax, A. Protein backbone angle restraints from searching a database for chemical shift and sequence homology. J. Biomol. NMR 13, 289-302 (1999).
36. Yuzawa, S. et al. Solution structure of the tandem Src homology 3 domains of p47phox in an autoinhibited form. J. Biol. Chem. 279, 29752-29760 (2004).
37. Akagi, T., Sasai, K. & Hanafusa, H. Refractory nature of normal human diploid fibroblasts with respect to oncogene-mediated transformation. Proc. Natl. Acad. Sci. USA, 100, 13567-13572 (2003).